Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Current Assets (2019 - 2025)

Historic Current Assets for Strata Critical Medical (SRTA) over the last 7 years, with Q3 2025 value amounting to $122.5 million.

  • Strata Critical Medical's Current Assets fell 2869.0% to $122.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.5 million, marking a year-over-year decrease of 2869.0%. This contributed to the annual value of $160.7 million for FY2024, which is 2206.86% down from last year.
  • Strata Critical Medical's Current Assets amounted to $122.5 million in Q3 2025, which was down 2869.0% from $156.5 million recorded in Q2 2025.
  • In the past 5 years, Strata Critical Medical's Current Assets registered a high of $342.7 million during Q2 2021, and its lowest value of $608720.0 during Q1 2021.
  • Moreover, its 5-year median value for Current Assets was $208.7 million (2023), whereas its average is $207.0 million.
  • In the last 5 years, Strata Critical Medical's Current Assets crashed by 5098.71% in 2021 and then surged by 4676193.98% in 2022.
  • Over the past 5 years, Strata Critical Medical's Current Assets (Quarter) stood at $294.9 million in 2021, then fell by 26.05% to $218.1 million in 2022, then dropped by 5.44% to $206.3 million in 2023, then dropped by 22.07% to $160.7 million in 2024, then fell by 23.8% to $122.5 million in 2025.
  • Its Current Assets stands at $122.5 million for Q3 2025, versus $156.5 million for Q2 2025 and $152.3 million for Q1 2025.